Alliance Pharma plc (AIM: APH)
42.75
+0.75 (1.79%)
Sep 11, 2024, 5:06 PM GMT+1
Alliance Pharma Company Description
Alliance Pharma plc acquires, markets, and distributes consumer healthcare products and prescription medicines in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas.
It provides its products under the Aloclair, Anbesol, Asthon & Parsons, Forceval, Hydromol, Kelo-Cote, MacuShield, Vamousse, Nizoral, and Amberen brand names.
The company was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.
Alliance Pharma plc
Country | United Kingdom |
Founded | 1996 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 292 |
CEO | Nicholas Sedgwick |
Contact Details
Address: Avonbridge House Chippenham, SN15 2BB United Kingdom | |
Phone | 44 12 4946 6966 |
Website | alliancepharmaceuticals.com |
Stock Details
Ticker Symbol | APH |
Exchange | London Stock Exchange AIM |
Fiscal Year | January - December |
Reporting Currency | GBP |
ISIN Number | GB0031030819 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Nicholas Sedgwick | Chief Executive Officer |
Andrew Franklin | Chief Financial Officer |
Jeyan Heper | Chief Operating Officer |
Cora McCallum | Head of Investor Relations |